Your browser doesn't support javascript.
loading
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
Bock, Magnus; Van Hasselt, Johan G C; Schwartz, Franziska; Wang, Hengzhuang; Høiby, Niels; Fuursted, Kurt; Ihlemann, Nikolaj; Gill, Sabine; Christiansen, Ulrik; Bruun, Niels Eske; Elming, Hanne; Povlsen, Jonas A; Køber, Lars; Høfsten, Dan E; Fosbøl, Emil L; Pries-Heje, Mia M; Christensen, Jens Jørgen; Rosenvinge, Flemming S; Torp-Pedersen, Christian; Helweg-Larsen, Jannik; Tønder, Niels; Iversen, Kasper; Bundgaard, Henning; Moser, Claus.
Affiliation
  • Bock M; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Van Hasselt JGC; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Schwartz F; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Wang H; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Høiby N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Fuursted K; Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Ihlemann N; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Gill S; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Christiansen U; Department of Cardiology, Bispebjerg Hospital, Copenhagen, Denmark.
  • Bruun NE; Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Elming H; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Povlsen JA; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Køber L; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
  • Høfsten DE; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Fosbøl EL; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
  • Pries-Heje MM; Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
  • Christensen JJ; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Rosenvinge FS; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Torp-Pedersen C; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Helweg-Larsen J; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Tønder N; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Iversen K; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Bundgaard H; The Regional Department of Clinical Microbiology, Region Zealand, Slagelse, Denmark.
  • Moser C; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
J Antimicrob Chemother ; 78(12): 2840-2848, 2023 12 01.
Article in En | MEDLINE | ID: mdl-37823408
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Endocarditis, Bacterial Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Endocarditis, Bacterial Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2023 Document type: Article Affiliation country: Country of publication: